Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-21-129658
Filing Date
2021-10-26
Accepted
2021-10-25 21:08:15
Documents
2
Group Members
CCUR HOLDINGS, INC.DAVID S. OROSJDS1, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2131034d1_sc13da.htm SC 13D/A 148641
2 EXHIBIT 99.2 tm2131034d1_ex99-2.htm EX-99.2 5470
  Complete submission text file 0001104659-21-129658.txt   155531
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82442 | Film No.: 211345732
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2200 FLETCHER AVENUE SUITE 501 FORT LEE NJ 07024
Business Address
SINGER JULIAN D. (Filed by) CIK: 0001628706 (see all company filings)

Type: SC 13D/A